Vaccinia Virus Protein C6 Is a Virulence Factor that Binds TBK-1 Adaptor Proteins and Inhibits Activation of IRF3 and IRF7

English version České info

Recognition of viruses by pattern recognition receptors (PRRs) causes interferon-β (IFN-β) induction, a key event in the anti-viral innate immune response, and also a target of viral immune evasion. Here the vaccinia virus (VACV) protein C6 is identified as an inhibitor of PRR-induced IFN-β expression by a functional screen of select VACV open reading frames expressed individually in mammalian cells. C6 is a member of a family of Bcl-2-like poxvirus proteins, many of which have been shown to inhibit innate immune signalling pathways. PRRs activate both NF-κB and IFN regulatory factors (IRFs) to activate the IFN-β promoter induction. Data presented here show that C6 inhibits IRF3 activation and translocation into the nucleus, but does not inhibit NF-κB activation. C6 inhibits IRF3 and IRF7 activation downstream of the kinases TANK binding kinase 1 (TBK1) and IκB kinase-ε (IKKε), which phosphorylate and activate these IRFs. However, C6 does not inhibit TBK1- and IKKε-independent IRF7 activation or the induction of promoters by constitutively active forms of IRF3 or IRF7, indicating that C6 acts at the level of the TBK1/IKKε complex. Consistent with this notion, C6 immunoprecipitated with the TBK1 complex scaffold proteins TANK, SINTBAD and NAP1. C6 is expressed early during infection and is present in both nucleus and cytoplasm. Mutant viruses in which the C6L gene is deleted, or mutated so that the C6 protein is not expressed, replicated normally in cell culture but were attenuated in two in vivo models of infection compared to wild type and revertant controls. Thus C6 contributes to VACV virulence and might do so via the inhibition of PRR-induced activation of IRF3 and IRF7.

Vyšlo v časopise: Vaccinia Virus Protein C6 Is a Virulence Factor that Binds TBK-1 Adaptor Proteins and Inhibits Activation of IRF3 and IRF7. PLoS Pathog 7(9): e32767. doi:10.1371/journal.ppat.1002247
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002247

Souhrn

Zdroje

1. SadlerAJWilliamsBR 2008 Interferon-inducible antiviral effectors. Nat Rev Immunol 8 559 568

2. StetsonDBMedzhitovR 2006 Type I interferons in host defense. Immunity 25 373 381

3. HornungVEllegastJKimSBrzozkaKJungA 2006 5′-Triphosphate RNA Is the Ligand for RIG-I. Science 314 994 997

4. KatoHTakeuchiOSatoSYoneyamaMYamamotoM 2006 Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 101 105

5. PichlmairASchulzOTanCPNaslundTILiljestromP 2006 RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314 997 1001

6. YoneyamaMKikuchiMNatsukawaTShinobuNImaizumiT 2004 The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5 730 737

7. O'NeillLABowieAG Sensing and signaling in antiviral innate immunity. Curr Biol 20 R328 333

8. AblasserABauernfeindFHartmannGLatzEFitzgeraldKA 2009 RIG-I-dependent sensing of poly(dA∶dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 10 1065 1072

9. BurckstummerTBaumannCBlumlSDixitEDurnbergerG 2009 An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 10 266 272

10. ChiuYHMacmillanJBChenZJ 2009 RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138 576 591

11. Fernandes-AlnemriTYuJWDattaPWuJAlnemriES 2009 AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458 509 513

12. RobertsTLIdrisADunnJAKellyGMBurntonCM 2009 HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323 1057 1060

13. TakaokaAWangZChoiMKYanaiHNegishiH 2007 DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature

14. UnterholznerLKeatingSEBaranMHoranKAJensenSB 2010 IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11 997 1004

15. HornungVAblasserACharrel-DennisMBauernfeindFHorvathG 2009 AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458 514 518

16. GuoBChengG 2007 Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J Biol Chem 282 11817 11826

17. RyzhakovGRandowF 2007 SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J 26 3180 3190

18. SasaiMShingaiMFunamiKYoneyamaMFujitaT 2006 NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J Immunol 177 8676 8683

19. KawaiTTakahashiKSatoSCobanCKumarH 2005 IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6 981 988

20. MeylanECurranJHofmannKMoradpourDBinderM 2005 Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 1167 1172

21. SethRBSunLEaC-KChenZJ 2005 Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3. Cell 122 669 682

22. IshikawaHBarberGN 2008 STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455 674 678

23. IshikawaHMaZBarberGN 2009 STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461 788 792

24. OshiumiHSasaiMShidaKFujitaTMatsumotoM 2003 TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J Biol Chem 278 49751 49762

25. YamamotoMSatoSHemmiHHoshinoKKaishoT 2003 Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 640 643

26. BowieAG 2010 TRAF3: uncovering the real but restricted role in human. Immunity 33 293 295

27. AuWCMoorePALowtherWJuangYTPithaPM 1995 Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci U S A 92 11657 11661

28. GrandvauxNServantMJtenOeverBSenGCBalachandranS 2002 Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol 76 5532 5539

29. HondaKYanaiHNegishiHAsagiriMSatoM 2005 IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 772 777

30. SatoMSuemoriHHataNAsagiriMOgasawaraK 2000 Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13 539 548

31. KawaiTSatoSIshiiKJCobanCHemmiH 2004 Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5 1061 1068

32. HoshinoKSugiyamaTMatsumotoMTanakaTSaitoM 2006 IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 440 949 953

33. MullerUSteinhoffUReisLFHemmiSPavlovicJ 1994 Functional role of type I and type II interferons in antiviral defense. Science 264 1918 1921

34. RandallREGoodbournS 2008 Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89 1 47

35. BowieAGUnterholznerL 2008 Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 8 911 922

36. PerdigueroBEstebanM 2009 The interferon system and vaccinia virus evasion mechanisms. J Interferon Cytokine Res 29 581 598

37. SmithGLChanYCHowardST 1991 Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repetition. J Gen Virol 72 1349 1376

38. GonzalezJMEstebanM 2010 A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary history. Virol J 7 59

39. OdaSSchroderMKhanAR 2009 Structural basis for targeting of human RNA helicase DDX3 by poxvirus protein K7. Structure 17 1528 1537

40. GrahamSCBaharMWCooraySChenRAWhalenDM 2008 Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog 4 e1000128

41. AoyagiMZhaiDJinCAleshinAEStecB 2007 Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein. Protein Sci 16 118 124

42. CooraySBaharMWAbresciaNGMcVeyCEBartlettNW 2007 Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol 88 1656 1666

43. KvansakulMYangHFairlieWDCzabotarPEFischerSF 2008 Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ 15 1564 1571

44. KalverdaAPThompsonGSVogelASchroderMBowieAG 2008 Poxvirus K7 Protein Adopts a Bcl-2 Fold: Biochemical Mapping of Its Interactions with Human DEAD Box RNA Helicase DDX3. J Mol Biol

45. DiPernaGStackJBowieAGBoydAKotwalG 2004 Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J Biol Chem 279 36570 36578

46. GubserCHueSKellamPSmithGL 2004 Poxvirus genomes: a phylogenetic analysis. J Gen Virol 85 105 117

47. ChenRARyzhakovGCooraySRandowFSmithGL 2008 Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog 4 e22

48. LinRHeylbroeckCPithaPMHiscottJ 1998 Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18 2986 2996

49. HondaKTaniguchiT 2006 IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6 644 658

50. KawaiTSatoSIshiiKJCobanCHemmiH 2004 Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5 1061 1068

51. ThurstonTLRyzhakovGBloorSvon MuhlinenNRandowF 2009 The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat Immunol 10 1215 1221

52. ClarkKPlaterLPeggieMCohenP 2009 Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J Biol Chem 284 14136 14146

53. Barrios-RodilesMBrownKROzdamarBBoseRLiuZ 2005 High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307 1621 1625

54. AssarssonEGreenbaumJASundstromMSchafferLHammondJA 2008 Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc Natl Acad Sci U S A 105 2140 2145

55. NilesEGSetoJ 1988 Vaccinia virus gene D8 encodes a virion transmembrane protein. J Virol 62 3772 3778

56. StackJHagaIRSchroderMBartlettNWMaloneyG 2005 Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med 201 1007 1018

57. HarteMTHagaIRMaloneyGGrayPReadingPC 2003 The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med 197 343 351

58. SchroderMBaranMBowieAG 2008 Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J 27 2147 2157

59. FujitaFTaniguchiYKatoTNaritaYFuruyaA 2003 Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. Mol Cell Biol 23 7780 7793

60. PomerantzJLBaltimoreD 1999 NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 18 6694 6704

61. SiuKLKokKHNgMHPoonVKYuenKY 2009 Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex. J Biol Chem 284 16202 16209

62. JacobsBLLanglandJOKiblerKVDenzlerKLWhiteSD 2009 Vaccinia virus vaccines: past, present and future. Antiviral Res 84 1 13

63. KirnDHThorneSH 2009 Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer. Nat Rev Cancer 9 64 71

64. ParkinsonJESmithGL 1994 Vaccinia virus gene A36R encodes a M(r) 43–50 K protein on the surface of extracellular enveloped virus. Virology 204 376 390

65. FalknerFGMossB 1988 Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J Virol 62 1849 1854

66. WilliamsonJDReithRWJeffreyLJArrandJRMackettM 1990 Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route. J Gen Virol 71 Pt 11 2761 2767

67. AlcamiASmithGL 1992 A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71 153 167

68. TscharkeDCSmithGL 1999 A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. J Gen Virol 80 Pt 10 2751 2755

69. TscharkeDCReadingPCSmithGL 2002 Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J Gen Virol 83 1977 1986